Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, efficacy, and pharmacokinetics of JTE-162 in subjects with cryopyrin-associated periodic syndrome (CAPS) is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryopyrin-associated Periodic Syndrome

Drugs mentioned

• JTE-162

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Cryopyrin-associated Periodic Syndromes (CAPS) | Phase 1 | Status: RECRUITING